100 related articles for article (PubMed ID: 9933852)
21. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics.
Cotes PM; Pippard MJ; Reid CD; Winearls CG; Oliver DO; Royston JP
Q J Med; 1989 Feb; 70(262):113-37. PubMed ID: 2594953
[TBL] [Abstract][Full Text] [Related]
22. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of recombinant erythropoietin for stimulating erythropoiesis after blood loss and surgery. An experimental study in rats.
Hoynck van Papendrecht MA; Jeekel H; Busch OR; Marquet RL
Eur J Surg; 1992 Feb; 158(2):83-7. PubMed ID: 1350220
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.
Dusenbery KE; McGuire WA; Holt PJ; Carson LF; Fowler JM; Twiggs LB; Potish RA
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1079-84. PubMed ID: 8083076
[TBL] [Abstract][Full Text] [Related]
25. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
26. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
Schreiber S; Howaldt S; Schnoor M; Nikolaus S; Bauditz J; Gasché C; Lochs H; Raedler A
N Engl J Med; 1996 Mar; 334(10):619-23. PubMed ID: 8592524
[TBL] [Abstract][Full Text] [Related]
27. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response].
León Molinari P; Jiménez Monteagudo M; Barona Zamora P; Riol Diego M; Castro Paz L; Sierrasesúmaga Ariznavarreta L
An Esp Pediatr; 1998 Jul; 49(1):17-22. PubMed ID: 9718761
[TBL] [Abstract][Full Text] [Related]
28. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis.
Brugnara C; Colella GM; Cremins J; Langley RC; Schneider TJ; Rutherford CJ; Goldberg MA
J Lab Clin Med; 1994 May; 123(5):660-7. PubMed ID: 8195672
[TBL] [Abstract][Full Text] [Related]
29. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
30. [Effect of recombinant human erythropoietin on autologous blood donation for heart surgery].
Szöcs M; Donauer E; Simon J; Gál G; Kovács G
Orv Hetil; 1995 Aug; 136(33):1777-81. PubMed ID: 7651714
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin response in critically ill mechanically ventilated patients: a prospective observational study.
DeAngelo AJ; Bell DG; Quinn MW; Long DE; Ouellette DR
Crit Care; 2005 Jun; 9(3):R172-6. PubMed ID: 15987387
[TBL] [Abstract][Full Text] [Related]
32. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer.
Henry DH
Semin Hematol; 1993 Oct; 30(4 Suppl 6):12-6. PubMed ID: 8153671
[TBL] [Abstract][Full Text] [Related]
34. Monitoring considerations in recombinant human erythropoietin therapy.
Ogden DA
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
[TBL] [Abstract][Full Text] [Related]
35. Variable efficacy of recombinant human erythropoietin in anemic pregnant women with different forms of heterozygous hemoglobinopathy.
Bencaiova G; Krafft A; Burkhardt T; Breymann C
Acta Haematol; 2006; 116(4):259-65. PubMed ID: 17119327
[TBL] [Abstract][Full Text] [Related]
36. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
Spicka I; Haber J; Petruzelka L; Kolesková E; Sálková J; Straub J; Zounar R; Klener P
Cas Lek Cesk; 1996 Jul; 135(14):450-3. PubMed ID: 8925545
[TBL] [Abstract][Full Text] [Related]
37. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.
van Iperen CE; Gaillard CA; Kraaijenhagen RJ; Braam BG; Marx JJ; van de Wiel A
Crit Care Med; 2000 Aug; 28(8):2773-8. PubMed ID: 10966249
[TBL] [Abstract][Full Text] [Related]
38. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
[TBL] [Abstract][Full Text] [Related]
39. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.
Howarth JE; Waters HM; Shanks D; Hyde K; Yin JA; Geary CG; Anastassiades E; Howarth D; Gokal R
J Clin Pathol; 1993 Jan; 46(1):41-4. PubMed ID: 8432886
[TBL] [Abstract][Full Text] [Related]
40. Enteral erythropoietin and iron stimulate erythropoiesis in suckling rats.
Kling PJ; Willeitner A; Dvorak B; Blohowiak SE
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):202-7. PubMed ID: 18223381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
